Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secukinumab in active rheumatoid arthritis despite methotrexate
NCT00928512Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 2 trial of secukinumab in rheumatoid arthritis (RA), sponsored by Novartis. Started Jul 2009; status: completed.
02
Drugs
secukinumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00928512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928512.